Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.
Gao ZG, Duong HT, Sonina T, Kim SK, Van Rompaey P, Van Calenbergh S, Mamedova L, Kim HO, Kim MJ, Kim AY, Liang BT, Jeong LS, Jacobson KA.
Gao ZG, et al. Among authors: kim ho, kim sk, kim ay, kim mj.
J Med Chem. 2006 May 4;49(9):2689-702. doi: 10.1021/jm050968b.
J Med Chem. 2006.
PMID: 16640329
Free PMC article.